ISOLATION OF LATENT 31-KDA C-TRUNCATED STROMELYSIN AND 21-KDA STROMELYSIN FROM RABBIT SYNOVIAL FIBROBLASTS - AN ALTERNATIVE ACTIVATION PATHWAY FOR STROMELYSIN
H. Kolkenbrock et al., ISOLATION OF LATENT 31-KDA C-TRUNCATED STROMELYSIN AND 21-KDA STROMELYSIN FROM RABBIT SYNOVIAL FIBROBLASTS - AN ALTERNATIVE ACTIVATION PATHWAY FOR STROMELYSIN, Biological chemistry Hoppe-Seyler, 375(4), 1994, pp. 241-247
The processing of culture medium of rabbit synovial fibroblasts led to
the isolation of three stromelysin-1 (MMP-3) cleavage products: A 31-
kDa protein, which represents a C-truncated latent stromelysin-1, an a
ctive stromelysin-1 of 21 kDa, that originates from the 31-kDa proform
by activation. A third protein had a molecular mass of 25 kDa represe
nting the C-terminal part of prostromelysin-1 and is missing in the C-
truncated latent stromelysin-1. The activation process of human prostr
omelysin-1 in vitro is known to lead to an active stromelysin-1 with a
relative molecular mass of 45 kDa by removing the N-terminal prodomai
n. This active stromelysin-1 is further processed to a lower molecular
mass active form of 28 kDa. Our results obtained for the highly homol
ogous rabbit stromelysin-1 ndicate that another activation pathway is
possible. In a first step prostromelysin-1; is hydrolysed between Met(
261)-Glu generating a C-truncated latent stromelysin-1, which is activ
ated by cleavage of the Thr(83)-Phe bond to the 21-kDa stromelysin-1.
The latent C-truncated stromelysin-1 is slowly converted even at 4 deg
rees C into the active form. In the presence of 50 mu M ZnCl2 this act
ivation was prevented for at least three weeks. The activation rate is
largely enhanced by aminophenylmercury acetate and especially by tryp
sin. The differences of the 21-kDa stromelysin-1 to a 28-kDa stromelys
in-1 isolated from human rheumatoid synovial fluids described earlier
are discussed.